Thermo Fisher Scientific Inc. is the world leader in serving science, with annual revenue over $40 billion. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. For more information, please visit www.thermofisher.com.
About our Pharma Services
Thermo Fisher Scientific provides industry-leading pharma services for drug development, clinical trial logistics, and commercial manufacturing through our Patheon™ brand. We partner with customers in the pharmaceutical, biotech, and life sciences industries as their trusted CDMO to deliver medicine to patients faster. We believe that doing this successfully not only requires science, technology, and world-class expertise, but also requires a strategic partnership—bonded by key elements such as trust, communication, and collaboration. We embed these elements into every operation, interaction, and step in the drug development journey. https://www.patheon.com/us/en/home.html
Thermo Fisher Scientific’s partnership goal is to collaborate closely with customers by providing integrated solutions—from research tools to Patheon CDMO services—that accelerate innovation and enable the efficient development and delivery of life-changing therapies.
Actively looking for scientific collaborations and to presnet our outlicensing assets to boost the technology transfer of my university.
Sandra Ramos Illán
Business Development Manager
Partnership Goal
From the Tech Transfer Office from Universidad Autónoma de Barcelona, we are seeking collaborations and partnerships to take our asset portfolio to the market.
Beatriz Monsalve
Innovation Manager
Partnership Goal
To connect UAB health technologies with industrial partners for licensing and joint value creation.
Busques innovació real per transformar la teva empresa?
Com oficina de transferència de la UB oferim a les empreses la possibilitat de millorar els seus productes i serveis a través de la contractació d’investigadors i grups de recerca de la Universitat de Barcelona.
Si ets una empresa, compta amb professionals de la universitat per dur a terme projectes innovadors que millorin la teva organització.
Cada any més de 600 projectes compten amb l'expertesa dels grups de recerca UB.
Comptem també amb equipaments pioners en tots els àmbits de coneixement, així com amb l’expertesa especialitzada.
Looking for real innovation to transform your company?
The UB transfer office offers companies the possibility of increasing their products and services through the contracting of researchers and research groups of the University of Barcelona.
If you are a company, involve both professionals from the university to complete innovative projects that benefit your organization.
Every year, more than 600 projects are included in the expertise of the UB research groups.
We also have pioneering equipment in all areas of connection, together with specialized experts.
VERSA Biomedical, before Specipig, is a pioneer Breeding and Biomedical Research Centre focused on the pig model. We breed miniature pigs and run in-vivo pig model preclinical studies for: - Medical device, tissue regeneration and new materials development: prototype, efficacy, biocompatibility, product knowledge, development and scientific evidence studies to attract investment and to develop the product. - Pharma preclinical development: efficacy, toxicology, pharmacokinetic, tolerance and proof of concept studies. We are GLP certified, have fully equipped surgery rooms and housing. Are experts on the pig model and we run stress management trainings with the animals to improve their welfare. We are at present working on the development on an Onco-pig model for use in preclinical studies.
● Versa Biomedical draws on Specipig's 13 years of experience as a preclinical CRO dedicated to designing flexible and personalized biomedical models. Thanks to this expertise, it will continue to offer innovative solutions to biomedical, pharmaceutical, biotechnology, and medical device companies.
● On its part, Specipig will focus on all activities related to the breeding and marketing of its own genetic line of miniature pigs, offering its services to other CROs.
● The goal of this strategic split is to enhance and reinforce the specialization of both companies, in order to provide a better service tailored to the specific needs of their clients. The differential value of Versa Biomedical + Specipig lies in the fact that they are two specialized companies in one.
At Vitae we research, formulate and manufacture at our own premises, scientific backet food supplements and medical devises. We sell all over Europe, Middle East, North Africa, South America and Canada
Werfen is a growing, family-owned, and innovative company founded in 1966 in Barcelona, Spain. We operate directly in nearly 30 countries and in more than 100 territories through distributors, with headquarters and Technology Centers located in Europe and the United States. The Immunoassay Technology Center in Barcelona has consolidated experience in the research, development, and manufacturing of IVD immunoassays and biomaterials.
Innovation is one of Werfen’s fundamental pillars, and we innovate at all levels, from diagnostic targets, biomaterials and reagents, protein production processes and assay technologies. We strive to strengthen our immunoassay know-how and technological capabilities with the ultimate goal of increasing efficiency and robustness, reducing time-to-market, and streamlining operations.
Werfen open innovation strategy is based on engagement with biotech companies and research institutions. We seek co-development or in-licensing opportunities.
Marina Bruch
Scientist
Partnership Goal
Werfen open innovation strategy is based on engagement with biotech companies and research institutions. We seek co-development or in-licensing opportunities.